The author of that SA article sounded like an amateur, but that isn’t a surprise with SA.
My best guess would be that the US institutional investors get tapped next. They set up that avenue last year.
I also beleive this because SI has indicated that he doesn’t want to partner the paediatric aGVHD program- which is what the phase 3 trial was for.
Instead he wants to partner the adult aGVHD, class 2/3 CHF (not class 4), RA and chronic lower back pain programs.
There does appear to be a strong shift in sentiment after the phase 3 success though, so you could be right- that may be the catalyst to CHF or chronic lower back pain getting over the line.
So I would be very happy to be proven wrong
- Forums
- ASX - By Stock
- MSB
- Cell Therapy News/Articles
Cell Therapy News/Articles, page-158
-
- There are more pages in this discussion • 17,660 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add MSB (ASX) to my watchlist
(20min delay)
|
|||||
Last
$1.10 |
Change
0.000(0.00%) |
Mkt cap ! $1.250B |
Open | High | Low | Value | Volume |
$1.09 | $1.13 | $1.08 | $5.380M | 4.893M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 69437 | $1.09 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.10 | 19999 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 69437 | 1.085 |
21 | 236832 | 1.080 |
7 | 104317 | 1.075 |
11 | 370859 | 1.070 |
2 | 53400 | 1.065 |
Price($) | Vol. | No. |
---|---|---|
1.095 | 19999 | 1 |
1.100 | 35400 | 3 |
1.105 | 32188 | 2 |
1.110 | 42480 | 5 |
1.120 | 97563 | 8 |
Last trade - 16.10pm 10/07/2024 (20 minute delay) ? |
Featured News
MSB (ASX) Chart |
The Watchlist
I88
INFINI RESOURCES LIMITED
Charles Armstrong, CEO
Charles Armstrong
CEO
SPONSORED BY The Market Online